A study from Japan showed that neoadjuvant chemoradiotherapy on rectal cancer increased the CD8 + tumor infiltrating lymphocytes compared to patients not given chemoradiotherapy [47], suggesting that anti-tumor immunity was enhanced by chemoradiotherapy. The gene discussed is CD8A; the disease is rectal cancer.